KR830003474A - 2-r-6-py-3(2h)-피리다지논이나 약제학적으로 가능한 그의 산부가염류의 제조방법 - Google Patents

2-r-6-py-3(2h)-피리다지논이나 약제학적으로 가능한 그의 산부가염류의 제조방법 Download PDF

Info

Publication number
KR830003474A
KR830003474A KR1019800003375A KR800003375A KR830003474A KR 830003474 A KR830003474 A KR 830003474A KR 1019800003375 A KR1019800003375 A KR 1019800003375A KR 800003375 A KR800003375 A KR 800003375A KR 830003474 A KR830003474 A KR 830003474A
Authority
KR
South Korea
Prior art keywords
pyridazinone
preparing
pharmaceutically acceptable
addition salt
acid addition
Prior art date
Application number
KR1019800003375A
Other languages
English (en)
Inventor
와이 레셔어 죠오지
보오든 디킨슨 윌리암
Original Assignee
제이므즈 에이취 루우서
스터어링 드럭그 인코포레이팃드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제이므즈 에이취 루우서, 스터어링 드럭그 인코포레이팃드 filed Critical 제이므즈 에이취 루우서
Publication of KR830003474A publication Critical patent/KR830003474A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57Nitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

내용 없음

Description

2-R-PY-3(2H)-파리다지논이나 약제학적으로 가능한 그의 산부가염류의 제조방법.
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 상응하는 2-R-4,5-디하이드로-6-PY-3(2H)-피리다지논을 탈수소화제와 반응시켜 구조식(Ⅰ)의 2-R-6-PY-3(2H)-피리다지논이나 약제학적으로 가능한 그의 산부가염을 제조하는 방법.
    여기서 PY는 1-2의 저급알킬 치환체를 갖는 4- 또는 3-피리딘일 이고 R은 수소, 저급알킬 또는 저급하이드록시 알킬이다.
  2. PY가 4-피리딘일 또는 3-피리니닐임을 특징으로하는 청구범위 제1항에 기재된 방법.
  3. R이 수소, 메틸, 에틸 또는 하이드록시에틸임을 특징으로 하는 청구범위 제1항에 기재된 방법.
  4. 2-R-4,5-디하이드로-6-PY-3(2H)-피리다지논을 초산내에서 부롬과 함께 가열하므로서 반응이 수행됨을 특징으로하는 청구범위 제1-3항에 기재된 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019800003375A 1979-08-30 1980-08-26 2-r-6-py-3(2h)-피리다지논이나 약제학적으로 가능한 그의 산부가염류의 제조방법 KR830003474A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7106579A 1979-08-30 1979-08-30
US71065 1979-08-30

Publications (1)

Publication Number Publication Date
KR830003474A true KR830003474A (ko) 1983-06-20

Family

ID=22099030

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019800003375A KR830003474A (ko) 1979-08-30 1980-08-26 2-r-6-py-3(2h)-피리다지논이나 약제학적으로 가능한 그의 산부가염류의 제조방법

Country Status (4)

Country Link
JP (1) JPS5634678A (ko)
KR (1) KR830003474A (ko)
BE (1) BE884859A (ko)
ZA (1) ZA805215B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4404203A (en) 1981-05-14 1983-09-13 Warner-Lambert Company Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents
US4397854A (en) 1981-05-14 1983-08-09 Warner-Lambert Company Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents
JPS60132494U (ja) * 1984-02-08 1985-09-04 堀庭 昌一 転写ししゆう布

Also Published As

Publication number Publication date
ZA805215B (en) 1981-08-26
BE884859A (fr) 1981-02-23
JPS5634678A (en) 1981-04-06

Similar Documents

Publication Publication Date Title
KR850001199A (ko) 1,8-나프티리딘 유도체의 제조법
KR880000433A (ko) 이미다조피리딘 및 중간체 화합물의 제조방법
KR860003241A (ko) 피페리딘 유도체의 제조방법
KR870002056A (ko) 치환된 프로파르길옥시아세토니트릴 유도체의 제조 방법
KR920008018A (ko) 피페라진 유도체의 제조방법
KR830003474A (ko) 2-r-6-py-3(2h)-피리다지논이나 약제학적으로 가능한 그의 산부가염류의 제조방법
KR830007631A (ko) 2-피리딘카복스아미드 유도체 및 이들의 제조방법
KR860003239A (ko) 퀴놀론 카복실산 유도체의 제조방법
KR870003092A (ko) 피리딘 유도체의 제조방법
KR850001724A (ko) 4-페닐-4-옥소-부텐-2-오인산유도체의 제조방법
KR830004292A (ko) 벤조구아나민 유도체의 제조방법
KR880011103A (ko) 5-아미노-4,6-디할로게노피리딘의 제조방법
KR850004481A (ko) 4, 5-디하이드로-6-[2-[4-(1h-이미다졸-1-일)페닐]-에테닐]-3(2h)-피리다지논류의 제법
KR830005191A (ko) 푸란유도체의 제조방법
KR840002821A (ko) N-(2,3-에폭시프로필렌)-n-아르알킬술폰아미드 유도체의 제조방법
JPS51118771A (en) Method for preparing carbostyryl derivatives
KR890002013A (ko) 치환된 피리딜알킬 케톤의 제조방법
KR890002011A (ko) 5-할로 게노-6-아미노-니코틴산 할라이드. 이의 제조방법 및 용도
KR840007409A (ko) 복소환 또는 치환에 의해 6위치에 치환된 아미드화 피리다진 유도체의 제조방법
KR830004290A (ko) 3-하이드라지노-6-py-피리다진이나 그의 산부가염의 제조방법
KR830005203A (ko) 6-(피리디닐)-4-치환-3(2h)-피리다지논의 제조방법
KR830005202A (ko) 4,5-디하이드로-6-(4-피리디닐)-3(2h) 피리다지논의 제조방법
KR840006801A (ko) 1,1-디치환-2-헤테로 사이콜릭 에탄올 유도체의 제조방법
KR960022468A (ko) 클로로메틸피리딘의 제조방법
KR840006642A (ko) 2-알콕시-5-(피리디닐)피리딘류의 제조방법